Who
John Harold Leaman
Director
Company insider
Files Form 4 as: Director, Traws Pharma; Chief Fin. & Business Officer, Impel Pharmaceuticals; CFO, Treas. & Hd Corp Strategy, Cartesian Therapeutics; Chief Financial Officer, Medgenics.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 13 Sep 2013
- Last trade
- 9 Jul 2026
- Last filed
- 14 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 14 Jul 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,150 at $0.00 | filing |
| 9 Jul 2026filed 14 Jul 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,150 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,435 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,435 at $0.00 | filing |
| 12 Dec 2025filed 16 Dec 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,234 at $0.00 | filing |
| 12 Dec 2025filed 16 Dec 2025 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Code A | —4,058 at $0.00 | filing |
| 21 Nov 2025filed 25 Nov 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,770 at $0.00 | filing |
| 1 Oct 2025filed 14 Oct 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,609 at $0.00 | filing |
| 14 Feb 2023filed 16 Feb 2023 | Impel Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 31 Dec 2022filed 4 Jan 2023 | Impel Pharmaceuticalsoption or derivative | SEC FORM 4 Code M | —10,571 at $0.00 | filing |
| 31 Dec 2022filed 4 Jan 2023 | Impel Pharmaceuticals | SEC FORM 4 Code M | —10,571 at $0.00 | filing |
| 31 Dec 2022filed 4 Jan 2023 | Impel Pharmaceuticals | SEC FORM 4 Code F | $14K3,627 at $3.75 | filing |
| 26 Jan 2022filed 28 Jan 2022 | Impel Neuropharmaoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 19 Oct 2021filed 21 Oct 2021 | Impel Neuropharmaoption or derivative | SEC FORM 4 Code A | —10,571 at $0.00 | filing |
| 20 Jul 2021filed 26 Jul 2021 | Impel Neuropharmaoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 15 Jun 2018filed 19 Jun 2018 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 17 Nov 2017filed 20 Nov 2017 | RNAC Cartesian Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —220,000 at $0.00 | filing |
| 18 Feb 2015filed 20 Feb 2015 | Medgenicsoption or derivative | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 16 Apr 2014filed 18 Apr 2014 | Medgenicsoption or derivative | SEC FORM 4 Code A | $55K10,314 at $5.37 | filing |
| 13 Sep 2013filed 17 Sep 2013 | Medgenicsoption or derivative | SEC FORM 4 Code A | —800,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.